On Friday, November 20th, at the International Conference on Cell-Based Therapies for Multiple Sclerosis in Lisbon, Portugal, Dr. Sadiq presented the most recent data about our FDA-approved Phase I stem cell trial. Peers from around the world came together to discuss the latest innovations in cell-based therapies for MS. Dr. Sadiq's encouraging data was well-received as it now provides some measureable results in the attempt to use stem cells to repair the damage caused by MS. Below are 2 slides from his presentation highlighting overall improvement and the dramatic increase in bladder function:
521 West 57th Street
4th Floor
New York, NY 10019
(646) 557-3900
Support Tisch MS and our innovative research leading to treatments that improve the lives of patients.